Log In
BCIQ
Print this Print this
 

Biosimilar peginterferon alfa-2a (PF694)

  Manage Alerts
Collapse Summary General Information
Company Pfenex Inc.
DescriptionBiosimilar of peginterferon alfa-2a, a pegylated recombinant interferon (IFN) alfa-2a
Molecular Target Type I interferon (IFN) receptor
Mechanism of ActionType I interferon (IFN) receptor agonist; Biosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat hepatitis C virus (HCV) infections
Regulatory Designation
PartnerStrides Arcolab Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today